E-LIB Suche - Ergebnisse für: Zaks, Tal

1

Clinical Development of mRNA Vaccines: Challenges and Oppor..:

, In: Current Topics in Microbiology and Immunology; mRNA Vaccines,

August, Allison ; Brito, Luis ; Paris, Robert. - p. 167-186 , 2022

Link: https://doi.org/10.1007/..

2

Preclinical and Clinical Demonstration of Immunogenicity by..:

Bahl, Kapil ; Senn, Joe J. ; Yuzhakov, Olga...
Molecular Therapy. 30 (2022) 8 - p. 2874 , 2022

Link: https://doi.org/10.1016/..

3

Author Correction: A phase 1 trial of lipid-encapsulated mR..:

August, Allison ; Attarwala, Husain Z. ; Himansu, Sunny...
Nature Medicine. 28 (2022) 5 - p. 1095-1096 , 2022

Link: https://doi.org/10.1038/..

4

Safety and Immunogenicity of an mRNA-Based Human Metapneumo..:

August, Allison ; Shaw, Christine A ; Lee, Heather...
Open Forum Infectious Diseases. 9 (2022) 7 - p. , 2022

Link: https://doi.org/10.1093/..

5

mRNA-encoded, constitutively active STINGV155M is a potent ..:

Tse, Sze-Wah ; McKinney, Kristine ; Walker, William...
Molecular Therapy. 29 (2021) 7 - p. 2227-2238 , 2021

Link: https://doi.org/10.1016/..

6

A phase 1 trial of lipid-encapsulated mRNA encoding a monoc..:

August, Allison ; Attarwala, Husain Z. ; Himansu, Sunny...
Nature Medicine. 27 (2021) 12 - p. 2224-2233 , 2021

Link: https://doi.org/10.1038/..

7

Lipid nanoparticles for mRNA delivery:

Hou, Xucheng ; Zaks, Tal ; Langer, Robert.
Nature Reviews Materials. 6 (2021) 12 - p. 1078-1094 , 2021

Link: https://doi.org/10.1038/..

8

Author Correction: Lipid nanoparticles for mRNA delivery:

Hou, Xucheng ; Zaks, Tal ; Langer, Robert.
Nature Reviews Materials. 7 (2021) 1 - p. 65-65 , 2021

Link: https://doi.org/10.1038/..

9

2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Ag..:

Shaw, Christine ; Lee, Heather ; Knightly, Conor...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S970-S970 , 2019

Link: https://doi.org/10.1093/..

10

mRNA vaccines against H10N8 and H7N9 influenza viruses of p..:

Feldman, Robert A. ; Fuhr, Rainard ; Smolenov, Igor...
Vaccine. 37 (2019) 25 - p. 3326-3334 , 2019

Link: https://doi.org/10.1016/..

11

Preclinical and Clinical Demonstration of Immunogenicity by..:

Bahl, Kapil ; Senn, Joe J. ; Yuzhakov, Olga...
Molecular Therapy. 25 (2017) 6 - p. 1316-1327 , 2017

Link: https://doi.org/10.1016/..

12

Target-specific randomized discontinuation trial design: a ..:

Galsky, Matthew D. ; Zaks, Tal ; Hassani, Habib...
Investigational New Drugs. 28 (2009) 2 - p. 194-198 , 2009

Link: https://doi.org/10.1007/..

13

A phase 1, open-label, multicenter study to assess the safe..:

Burris III, Howard A. ; Patel, Manish R. ; Cho, Daniel C....
Journal of Global Oncology. 5 (2019) suppl - p. 93-93 , 2019

Link: https://doi.org/10.1200/..

14

Target-specific, histology-independent, randomized disconti..:

Galsky, Matthew D. ; Von Hoff, Daniel D. ; Neubauer, Marcus...
Investigational New Drugs. 30 (2010) 2 - p. 695-701 , 2010

Link: https://doi.org/10.1007/..

15

High resolution genomic analysis of sporadic breast cancer ..:

Naylor, Tara L ; Greshock, Joel ; Wang, Yan...
Breast Cancer Research. 7 (2005) 6 - p. , 2005

Link: https://doi.org/10.1186/..